Effect of Abdominal Wall Activity on the Responses to Meal Ingestion

Sponsor
Hospital Universitari Vall d'Hebron Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT04691882
Collaborator
(none)
16
1
2
3.4
4.8

Study Details

Study Description

Brief Summary

Meal ingestion induces sensations that are influenced by a series of conditioning factors. Aim: to determine the effect of abdominal wall activity on the responses to a standard probe meal. Study in healthy subjects comparing postprandial digestive sensations (abdominal bloating and digestive well-being) during consecutive maneuvers of diaphragmatic contraction (i.e. descent) versus diaphragmatic relaxation (i.e. ascent) in a cross-over randomized design. Primary outcome: effect of somatic maneuvers on abdominal bloating sensation; secondary aim: effect on digestive well-being.

Participants (16 women) will be instructed to eat a standard dinner the day before, to consume a standard breakfast at home after overnight fast, and to report to the laboratory, where the test meal will be administered 4 h after breakfast. Studies will be conducted in a quiet, isolated room. Participants will be taught to produce diaphragmatic contraction and visible abdominal distention. A probe meal up to maximal satiation will be administered to induce abdominal fullness/bloating sensation; immediately after ingestion, bloating sensation (from 0 to 10) and digestive well-being (from -5 to +5) will be scored during 8 alternating episodes (30 s each) in random sequence of diaphragmatic contraction (abdominal distension) versus diaphragmatic relaxation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Diaphragmatic contraction
  • Behavioral: Diaphagmatic relaxation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Factors That Determine the Responses to Meal Ingestion: Effect of Abdominal Wall Activity
Actual Study Start Date :
Oct 12, 2020
Actual Primary Completion Date :
Jan 15, 2021
Actual Study Completion Date :
Jan 22, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diaphragmatic contraction

Behavioral: Diaphragmatic contraction
Sequential periods (30 s) of voluntary diaphragmatic contraction after meal ingestion

Active Comparator: Diaphragmatic relaxation

Behavioral: Diaphagmatic relaxation
Sequential periods (30 s) of voluntary diaphragmatic relaxation after meal ingestion

Outcome Measures

Primary Outcome Measures

  1. Changes in abdominal fullness/bloating sensation induced by the probe meal [10 min]

    Effect of abdominal wall activity on abdominal fullness/bloating [measured by 10 cm scale graded from 0 (not at all) to 10 (very much)]

Secondary Outcome Measures

  1. Changes in digestive well-being sensation induced by the probe meal [10 min]

    Effect of abdominal wall activity on digestive well-being [measured by 10 cm scale graded from -5 (extremely unpleasant sensation) to +5 (extremely unpleasant extremely pleasant sensation)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • non-obese
Exclusion Criteria:
  • history of gastrointestinal symptoms

  • prior obesity

  • use of medications

  • history of anosmia and ageusia

  • current dieting

  • alcohol abuse

  • psychological disorders

  • eating disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Vall d'Hebron Barcelona Spain 08035

Sponsors and Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital Universitari Vall d'Hebron Research Institute
ClinicalTrials.gov Identifier:
NCT04691882
Other Study ID Numbers:
  • PR(AG)338/2016K
First Posted:
Dec 31, 2020
Last Update Posted:
Feb 18, 2021
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospital Universitari Vall d'Hebron Research Institute

Study Results

No Results Posted as of Feb 18, 2021